Graft Failure: Clinical Trials

4 trials for Graft Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated, 1 unknown. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 21Terminated 1

Follow Graft Failure: new trials by email Literature Review of Graft Failure trials Research Report on Graft Failure

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tumescence in HNC Skin Graft Reconstruction
Tumescence During STSG Harvest - Head and Neck Cancer, Surgery--Complications
Phase 3Active not recruitingUniversity of California, Davis582021-09-012026-02-18
Intraoperative NIRS of Transplanted Kidney for Prediction of Acute and Sub-acute Injury
Invos Model 5100C Cerebral/Somatic Oximeter - Graft Failure
Phase 3UnknownTel-Aviv Sourasky Medical Center602021-01-012020-12-28
Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation
Heme arginate (Normosang), 0.9% sodium chloride - Graft Failure, Ischemia-reperfusion Injury
Phase 3CompletedUniversity of Edinburgh402012-01-012015-05-27
TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
Tacrolimus, HTK/Placebo - Terminal Liver Disease, Ischemia Reperfusion Injury
Phase 2 / Phase 3TerminatedLudwig-Maximilians - University of Munich252011-10-012017-03-23

Narrower conditions

Reperfusion Injury (2)  ·  Head and Neck Neoplasms (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Postoperative Complications (2)  ·  Vascular Diseases (2)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Hemin (1)  ·  Receptor, EphB4 (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Tacrolimus (1)  ·  heme arginate (1)

Sponsors

Ludwig-Maximilians - University of Munich (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of California, Davis (1)  ·  University of Edinburgh (1)

Countries

Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

David Kluth, PhD (1)  ·  Karl-Walter Jauch, M.D. (1)  ·  Lorna Marson, MD (1)  ·  Martin Angele, M.D. (1)  ·  Rachel Thomas, MBChB (1)  ·  Sebastian Pratschke, M.D. (1)  ·  Stephen McNally, PhD (1)

Results publications

PMID 23497558, PMID 26680374, PMID 27500266